Inhibiting FABP5 represents a unique mechanism of action with ART26.12 standing out as a first-in-class candidate ... ECGs, clinical laboratory tests, physical examinations, and visual analogue mood ...

Effects on clinical parameters including days with lesions ... into Phase 1b studies after each long-acting helicase-primase inhibitor candidate exceeded the company’s target PK profiles in Phase 1a ...

Press Release Nicox Announces Last Patient Completes the NCX 470 Denali Phase 3 Clinical Trial Results expected mid-August to ...

The primary endpoint of 12-month Event Free Survival (EFS) for OST-HER2- treated patients (35%) was statistically significant (p= 0.0194) when compared with peer-reviewed comparable historical control ...

Pliant Therapeutics has terminated its idiopathic pulmonary fibrosis (IPF) program after digging into the increased rate of adverse events from a 2b/3 trial of its lead candidate bexotegrast. Back in ...

Liver and Lipid Profile ... is a clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics for neurologic, neuropsychiatric, and metabolic disorders.

Phase 1b study supports proof-of-concept in DOK7 congenital myasthenic syndromes Advancing ARGX-119 further validates strong track record of Immunology Innovation Program (IIP), argenx's collaborative ...

Early animal studies showed strong plasma exposure and a promising pharmacokinetic profile indicative of central nervous ... with the goal of advancing one or more drug candidates into human clinical ...

Clinical safety : Data from two human Phase 3 studies in Alzheimer's disease demonstrated a favorable safety profile. “My research and collaboration ... under development are investigational product ...

Philadelphia, Pennsylvania--(Newsfile Corp. - June 30, 2025) - Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus") and Antev Ltd. ("Antev"), a UK-based clinical-stage drug development company, announced ...

He occupied various positions in the department over five years during the early 2000s, according to his LinkedIn profile. But it is what he did ... be made available after the very first stage of ...